PMID- 28972400 OWN - NLM STAT- MEDLINE DCOM- 20171219 LR - 20171219 IS - 1557-7430 (Electronic) IS - 1044-5498 (Linking) VI - 36 IP - 12 DP - 2017 Dec TI - Knockdown of miR-629 Inhibits Ovarian Cancer Malignant Behaviors by Targeting Testis-Specific Y-Like Protein 5. PG - 1108-1116 LID - 10.1089/dna.2017.3904 [doi] AB - Ovarian cancer (OC) is the most lethal gynecological cancer. The molecular mechanism of it is complicated, and numerous researches suggest that microRNAs are key regulators for it. This study was to investigate the pivotal role of miR-629 in the progression of OC and to reveal the possible molecular mechanism of its action. Testis-specific Y-like protein 5 (TSPYL5) is a tumor suppressor gene in various cancers, but there is little for its role in OC. OC OVCAR3 cells were transfected with the miR-629 vector, miR-629 inhibitor, and/or small interfering RNA (siRNA) targeting TSPYL5 (si-TSPYL5), respectively. After transfection, cell apoptosis, the ability of migration, and invasion were explored, as well as the level of miR-629 and TSPYL5 protein expression were detected by quantitative polymerase chain reaction and western blot. Compared with the control, there was increasing of miR-629, and decreasing of TSPYL5 and caspase 3 in OC tissue. Overexpression of miR-629 promoted the cell ability of migration and invasion and reduced OC cell apoptosis. In addition, elevated cancer inhibition ability of TSPYL5 induced by the miR-629 inhibitor was significantly blocked by inhibition of TSPYL5 (si-TSPYL5). All the above results suggested that miR-629 could promote OC proliferation, migration, and invasion by directly suppressing TSPYL5 expression, and inhibition of miR-629 might serve as a therapeutic target for OC. FAU - Shao, Liping AU - Shao L AD - 1 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University , Suzhou, China . AD - 2 Department of Obstetrics and Gynecology, The People's Hospital of Suzhou National New & Hi-Tech Development Zone , Suzhou, China . AD - 3 Department of Obstetrics and Gynecology, Taixing People's Hospital , Taizhou, China . FAU - Shen, Zongji AU - Shen Z AD - 1 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University , Suzhou, China . FAU - Qian, Hua AU - Qian H AD - 3 Department of Obstetrics and Gynecology, Taixing People's Hospital , Taizhou, China . FAU - Zhou, Sufang AU - Zhou S AD - 2 Department of Obstetrics and Gynecology, The People's Hospital of Suzhou National New & Hi-Tech Development Zone , Suzhou, China . FAU - Chen, Youguo AU - Chen Y AD - 1 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University , Suzhou, China . LA - eng PT - Journal Article DEP - 20171003 PL - United States TA - DNA Cell Biol JT - DNA and cell biology JID - 9004522 RN - 0 (MIRN629 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (Nuclear Proteins) RN - 0 (RNA, Neoplasm) RN - 0 (RNA, Small Interfering) RN - 0 (TSPYL5 protein, human) SB - IM MH - Apoptosis/genetics MH - Cell Line, Tumor MH - Cell Movement/genetics MH - Cell Proliferation/genetics MH - Female MH - Gene Expression MH - Gene Knockdown Techniques MH - Humans MH - Male MH - MicroRNAs/*antagonists & inhibitors/*genetics/metabolism MH - Middle Aged MH - Neoplasm Invasiveness/genetics MH - Nuclear Proteins/*antagonists & inhibitors/*genetics/metabolism MH - Ovarian Neoplasms/*genetics/metabolism/pathology MH - RNA, Neoplasm/antagonists & inhibitors/genetics/metabolism MH - RNA, Small Interfering/genetics OTO - NOTNLM OT - TSPYL5 OT - cell proliferation OT - miR-629 OT - migration and invasion OT - ovarian cancer EDAT- 2017/10/04 06:00 MHDA- 2017/12/20 06:00 CRDT- 2017/10/04 06:00 PHST- 2017/10/04 06:00 [pubmed] PHST- 2017/12/20 06:00 [medline] PHST- 2017/10/04 06:00 [entrez] AID - 10.1089/dna.2017.3904 [doi] PST - ppublish SO - DNA Cell Biol. 2017 Dec;36(12):1108-1116. doi: 10.1089/dna.2017.3904. Epub 2017 Oct 3.